Table 1 Example of the extracted fields in CliniFact.
From: A dataset for evaluating clinical research claims in large language models
NCTID | NCT00234065 |
|---|---|
PMID | 20833591 |
Outcome Title | Numbers of Patients With First Occurence of Stroke |
Outcome Time Frame | From start of treatment to end of follow-up period (follow-up periods: 29 months [Standard Deviation 16, range 1–59 months]) |
Intervention | Cilostazol |
Comparator | Aspirin |
Type of Statistical Test | Non-Inferiority or Equivalence |
Publication Title | Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial. |
Publication Abstract | […] Interpretation: Cilostazol seems to be non-inferior, and might be superior, to aspirin for prevention of stroke after an ischaemic stroke, and was associated with fewer haemorrhagic events. Therefore, cilostazol could be used for prevention of stroke in patients with non-cardioembolic stroke. […] |
Hypothesis Label | Evidence |
